China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	19.17B -2.5%
Revenue (ttm)	11.00B -1.9%
Net Income	1.65B +1.2%
EPS	1.59 +0.6%
Shares Out	1.03B
PE Ratio	11.65
Forward PE	10.95
Dividend	0.48 (2.60%)
Ex-Dividend Date	Oct 28, 2025

Volume	13,677,424
Average Volume	9,842,287
Open	18.55
Previous Close	18.41
Day's Range	18.35 - 18.64
52-Week Range	17.34 - 22.14
Beta	0.05
RSI	52.18
Earnings Date	Mar 20, 2026

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2025, SHA:600062's revenue was 11.00 billion, a decrease of -1.88% compared to the previous year's 11.21 billion. Earnings were 1.65 billion, an increase of 1.18%.